Company intelligence / Profile preview

Alpha MOS

Toulouse, Occitanie, France

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Alpha MOS supplies commercial sensory analysis devices (electronic noses, tongues, eyes) to the food, beverage, and packaging industries globally. Its MedTech subsidiary BOYDSense completed a >100-patient early clinical trial for non-invasive breath-based glucose monitoring with promising results; platform is being readied for FDA submission and product manufacturing.

Therapeutic areas: OtherEndocrinology
Modalities: Device (electronic nose, electronic tongue, electronic eye)Sensor technologyDiagnostic device
Industry: Food & Nutrition

Partnerships

Coca-Cola Bottling Co. Consolidated (strategic for product development/sensory analysis)

Beyond the preview

Go deeper on Alpha MOS.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alpha MOS.

Explore the full profile